Tai W. Wong
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab(2007)1,126 cited
- → Regulated Interactions between Dynamin and the Actin-Binding Protein Cortactin Modulate Cell Shape(2000)387 cited
- → Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection(2007)343 cited
- → Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2011)275 cited
- → Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail(2007)247 cited
- → Both the conserved stem-loop and divergent 5'-flanking sequences are required for initiation at the human mitochondrial origin of light-strand DNA replication.